Research lead
The UK Nanotechnology Knowledge Transfer Network (NanoKTN), is holding its first Nano 4 Life event on Wednesday 11 February at the Wellcome Trust in London to bring together researchers, industry and policy makers to discuss how nanotechnology can be applied to healthcare and to advance product discovery and development.
The event is open to anyone who is interested in learning what nanotechnology has to offer the life sciences.
The field of bionanotechnology is developing rapidly and helping resolve some of the pharma and biotech sectors’ drug delivery challenges. “A significant number of healthcare solutions already involve nanotechnology and by organising the Nano 4 Life conference, we hope to develop a sustainable UK industry, reduce costs and bring together every part of the supply chain,” said Mike Fisher, of NanoKTN.
“In the future, nanotechnology will improve the drug discovery process through miniaturisation, automation, speed and reliability of assays,” said Fisher. “The use of nanotechnology can help bring product discovery and development costs down by improving efficiency and decreasing the risk of product failure.”
Speakers include Thomas Keller, from GlaxoSmithKline, Rachel McKendry from the London Centre for Nanotechnology and Ljeoma F. Uchegbu, Chair in Pharmaceutical Nanoscience in the School of Pharmacy at the University of London.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
